Our Mushrooms Aren't Magical, They're Therapeutic

We estimate a $100B potential market

PsiloThera. Is. Change.

Psilothera is a pioneering mental health care company dedicated to creative, modern solutions to treat global healthcare concerns, including depression, anxiety, PTSD, eating disorders, addictions, Alzheimer’s, dementia, and more. We plan to deploy quantum technology to shorten the drug development time, which will give us an advantage over our competitors. With a focus on healing, hope, and compassion, we aim to change the paradigm of mental healthcare with their Psilocybin-based therapies.

Reasons to Invest

Tackling A Global Mental Healthcare Crisis

Focusing on medical research breakthroughs & groundbreaking legalizations

Vertical Opportunity

Actively targeting a $100 billion market opportunity in Psilocybin healthcare

Battle-Tested  Management Team

Psilothera is backed by a business model, strategy and plan driven by research & development

Research & Development

Artificial Intelligence & Machine Learning

Drug & Nutraceutical Development

Quantum Technology


Mental Healthcare Therapeutic Platform

Psilocybin Therapy

Microdosing and Physician-Directed Therapy

We are in the middle of a Global Mental Health Crisis

Recent estimates from the World Health Organization show that roughly 322 Million People suffer from Major Depression Disorder. In the US alone, 16 million people suffer from this debilitating disease. What’s worse is that up to a third of the people suffering from clinical depression are “treatment resistant,” meaning traditional antidepressants don’t treat them. This resistance is one of the reasons why 17.6 veterans commit suicide a day in the United States. With the current state of the mental healthcare industry, they have no other options for medication.

Watch Video

Strong Executive Leadership, Experienced Operations Team, and Deep Advisory Relationships

John is a Visionary and Serial Entrepreneur with significant Executive Management experience. John will spearhead the development of the Psilothera Online Therapeutic Platform and shall oversee much of the Drug Development & Technology strategies and the utilization of Quantum Technology, Artificial Intelligence (AI) and Machine Learning (ML) to discover novel compounds and develop them into Therapeutics.

He is an Advocate for Psilocybin Decriminalization & Legalization and Testified in Support of Psilocybin Decriminalization at a Session of the State of Hawaii Legislature debating SB:38 on February 2021. John has a Successful track record of developing and working with next generation web based platforms & technologies for Healthcare & Medical Industries: Electronic Medical Record (EMR) Technologies, e-RX Technologies, Online Physician Platforms & Patient Wellness App.

Holly is the proud owner of Fun-gal Farms, a self owned and operated mushroom farm focused on culinary and medicinal varieties including Lion’s Mane, Chestnuts, Reishi, Nameko, King Trumpets, Turkey Tail, Pioppino, Black Pearl Kings, and many varieties of Oyster mushrooms. Holly began her journey into mushrooms as a young girl, spending endless days in the woods with her father searching for edibles and learning to cultivate shiitake.

Over the years, she has honed her skills in the lab singling out specific genetics to produce superior specimens. Many of the species currently grown were cloned directly from the wild.

She is looking forward to using these skills to bring only the best specimens to Psilothera.

Jacquelyn Wright-Minogue, MS, PMP has over 30 years of pharmaceutical industry experience Jackie first joined Schering-Plough in the pathology area. She then moved onto basic research and clinical research in several therapeutic areas such as pathology, virology, allergy and immunology, oncology and rare diseases.

Her cloning, RT-PCR and DNA sequencing knowledge and skills led her to an adjust professor teaching position at a Kean University where she taught master level courses in DNA sequencing.

Feeling the need to get closer to the patient experience after 20 years in basic scientific research, Jackie leaves Schering-Plough/Merck, and moves onto Novartis to work on oncology trials. Working on clinical trials for medulloblastoma in children and basal cell carcinoma. The drug was approved by the FDA as Sonidegib for locally advanced basal cell carcinoma.

From big pharma, Jackie moved onto a small biotech company called Amicus Therapeutics where she quickly advanced to her current role as Sr. Director of Clinical Operations. Jackie helped spearhead and enrolled the largest ever trial in Pompe Disease in record time, keeping patients on study during a global pandemic.

It is her life mission to get medication to those in need. During the pandemic more people are suffering from mental illness than ever before. Jackie believes that this unmet medical need could benefit from a healthier, natural option with fewer side effects than traditional medicine.

Chaplain Chuck will spearhead our clinical approach and shall develop our Veteran & Civilian Psilocybin Therapeutic Studies and Programs & Suicide Prevention Programs.

Chaplain Chuck trained hundreds of military personnel once a year in suicide prevention for 16 years. He has also been Certified to Train First Responders on suicide intervention.

An Iraqi Combat Vet, he has served 25 years in the military as an Army Chaplain and as a Behavioral Science Specialist. Chuck has a MSW Degree in Social Work from Marywood University and a MS in Experimental Psychology from Purdue University and a BA in Psychology from Seton Hall University.

Notable Service of Achievement and Invaluable Experience: Awarded Bronze Star & GWOT Expeditionary Medal for Military Service, 2003-2004. GWOT=Global War on Terrorism. Operation Iraqi Freedom; Awarded General Petraeus Excellence in Combat Coin.

Chaplain Chuck has provided compassionate spiritual needs assessments, care & counseling to increase the resiliency of hundreds of individuals, couples and families in: burn wards, combat operations, in-patient psychiatric wards critical incidents, emergency rooms, funeral homes, hospice, hospitals, memorials, military deployments and exercises, nursing homes, orphanages, prisons, relationship enhancement retreats and work officesettings.

Michelle is a Certified Clinical Trauma Professional, clinically trained in Somatic Experiencing, a method ideally suited to gently releasing the stress, anxiety, trauma and overwhelm trapped in one's body.

This powerful modality allows clients to quickly resolve past emotional issues so they can move forward with a sense of joy and freedom.

Her experiences working with Hospice, as well as providing intensive in-home therapy to families, has allowed Michelle the humbling privilege of walking with all types of individuals through some of life's most difficult circumstances.

Whatever your situation, she is available to meet you where you are and help you get to where you want to be.


  • Addiction
  • Adoption
  • Anxiety
  • Behavioral Issues
  • Depression
  • Divorce
  • Domestic Abuse
  • Family Conflict
  • Grief
  • Life Coaching
  • Life Transitions
  • Marital and Premarital
  • Parenting
  • Peer Relationships
  • School Issues
  • Self-Harming
  • Spirituality
  • Trauma & PTSD
  • Women's Issues

Types of Therapy:

  • Art Therapy
  • Attachment-based
  • Christian Counseling
  • Coaching
  • Cognitive Behavioral (CBT)
  • Dialectical (DBT)
  • EMDR
  • Eclectic
  • Emotional Focused
  • Gottman Method
  • Hypnotherapy
  • Imago
  • Internal Family Systems (IFS)
  • Intervention
  • Mindfulness-Based (MBCT)
  • Narrative
  • Neuro-Linguistic
  • Person-Centered
  • Somatic Experiencing

  • Strength-Based
  • Play Therapy
  • Positive Psychology
  • Reality Therapy
  • Solution Focused Brief(SFBT)
  • Somatic
  • Trauma-Focused
  • Modality:

    • Individuals
    • Couples
    • Family

    Dr. Rydfors received his Medical degree and specialization training from Stanford University Medical Center where he is an Adjunct Clinical Professor. Dr Rydfors has extensive experience in high risk Obstetrics, advanced fertility treatment and treatment of recurrent miscarriages.

    Over the last 30 years, Dr. Rydfors has developed a successful multidisciplinary program to prevent recurrent miscarriages which attracts patients from all over the US. His interests include also autism prevention in pregnancy. He is the initial creator and current Co-Author of the popular “Handbook in Obstetrics, Gynecology and Infertility,” now in its sixth edition, the main handbook used by all Obstetricians and Gynecologists in training in the US.

    He was the founder of OBOnTheGo and EmbraceHerHealth which made the most complete medical grade pregnancy Mobile Apps when they came out and currently is a co-founder of EverDoc where powerful AI and Machine Learning is being used to optimize medical care.

    He is the Chief Medical Advisor for the American Pregnancy Association and acts as a Medical Advisor for several Silicon Valley Companies.

    He is the recipient of the Compassionate Doctor, Marquis who’s who in the world and Patient’s Choice award. Dr. Rydfors is fluent in French, Spanish, Swedish and is proficient in Mandarin as well as other languages.

    Anthony will be part of our team that will be working with high risk patients. Anthony recently Earned his MA in Behavioral Analysis from Florida Institute of Technology and previously earned his BA from the University of Colorado in Neuroscience and Psychology.

    Anthony has worked at RBT since 2017 and has worked with individuals of all ages with a wide range of neurodevelopment disorders.

    His research Interest include the use of ABA with individuals with traumatic brain injuries and individuals with co-morbid mental health and neurodevelopment disorders diagnosis.

    Adam Bell has been designing and developing website projects for twenty-five years.

    He has worked on a variety of projects in the world of e-commerce and entertainment. Current projects are with Cafe du Monde, Tattoo Tequila, Skull + Monarch Auctions + Galleries and PowerAnimal Pet Foods. In the past he’s worked with the likes of Ovation TV, Amblin Partners, Tender Greens and the Ford Motor Company among many others. He’s worked with everyone from small startups to multi-national corporations.

    Adam is spearheading the development of a groundbreaking e-Mental Health initiative that will provide relief from suffering for millions of people.

    Leif’s passion for healing stems from the challenges he faced during a life-long battle with debilitating depression and anxiety. His tenacity and desire for emotional relief led him to seek treatment. After reading about the cutting-edge research that was done in Johns Hopkins University and Imperial College in London his intrigue led him to action. His psilocybin treatment along with his spirituality has clearly shown him that we were put here on this planet to serve. His biggest desire is for global awakening and he feels compelled to help people navigate through the deep waters of true self-discovery. Leif is determined and compelled to offer the guidance of his experience to transcend the pain and suffering of others in need.

    Daniel is a Linux Systems Engineer who currently designs compute environments for High Performance Clusters (HPC) and supercomputing at Carnegie

    Mellon University; supporting research in AI (AGI/ANI), Machine Learning, Deep Learning, Language Technologies, Robotics, Psychology and Astrophysics.

    Daniel believes we have a core responsibility to steward our resources to benefit humanity; especially to those in need of care.

    "Mystro" shall focus on opportunities to drive growth via strategic partners and alliances.

    Professionally, Mystro is a Music & Entertainment Industry Executive and iconic Vegas Music Director & Performer. He is a serial entrepreneur with business interests in the areas of Music Production, Internet & Technology, Craft Spirits, Cannabis, CBD & Quantum Technology.

    Spike Humer shall advise in areas of Business Development and Strategy. Spike is widely-recognized as a thought-leader and world-renowned expert in leading and inspiring companies, organizations, and individuals to achieve more, have more, and be more.

    He's been called the "mentor's mentor" and is highly regarded a master marketing strategist and performance acceleration expert. Spike serves as a trusted advisor and performance consultant to entrepreneurs and individuals from virtually every walk-of-life and in countless industries.

    He is an acclaimed author, speaker, thought-leader, and creator of "The 10 Day Turnaround Methodologies", "Rapid Success Technologies", and "The Overnight Entrepreneur" seminars, book and workshop series.

    Ed Galisewski has spend his entire career working in the field of Pharmaceutical sales. 29 years as a Virology/HIV Sales rep for Abbvie selling cutting edge Protease Inhibitors and now the last 5 years as the Regional Account Manager for Walgreens Specialty Pharmacy division covering several states.

    Ed has also serves for 35 years as a Lay Pastor for several large suburban churches as a Men's Ministry Director. His passion has always been about getting men together to talk freely about their life struggles and help them wrestle with their questions about faith.

    Ed is the author of two books that explore the concept of why people walk away from religion. "A Simpler Faith" and "Simplifying Religion" are his two book titles. His underlying goal for both books is to bring people back to faith in a world where Religion seems to be pushing people away from it.

    Anthony shall act as out legislative analyst and activist to promote the legalization of Psilocybin for use in therapeutic settings.

    Anthony has several years of experience working for former U.S. Rep. Leonard Lance of NJ and Senator Tom Kean and his issue coverage and focus was Healthcare, Infrastructure and Taxes.

    Mr. Biondi obtained his Law Degree from Thomas Jefferson School of Law in San Diego, California and has been practicing law in California since 2000. Mr. Biondi shall advise on a wide array of Corporate legal matters.

    Prior to his Law Career, he held positions in the Financial Services Industries and also he owned his own Contracting company. However, after undergoing a double-lung transplant in 1993, he was forced to change careers and eventually leading Glen to his career in Law.

    Zeke is a contemporary artist that has been commissioned to create existing brand imagery to inspire us all.

    This Psilothera, Inc. confidential presentation contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements.” Forward-looking statements can be identified by the use of words such as ”plans”, “expects” or ”does not expect”, “is expected”, ”estimates”, “intends”, ”anticipates” or “does not anticipate”, or ”believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, ”could”, “would”, ”might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, among others, dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing federal, provincial, municipal, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to operate and expand the Company’s facilities; engaging in activities which currently are illegal under United States federal law and the uncertainty of existing protection from United States federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including federal and provincial legalization, due to inconsistent public opinion, perception of the medical-use of psychedelic therapies, delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; the Company’s limited operating history and lack of historical profits; reliance on management; Psilothera’s requirements for additional financing, and the effect of capital market conditions and other factors on capital availability, including closing of the financings contemplated herein; competition, including from more established or better financed competitors; and the need to secure and maintain Academic & Corporate alliances and partnerships, including with customers and suppliers. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company has no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.
    © 2021 — PSILOTHERA® All rights reserved